Cancer far more commonly destroys appetite than increases it. The hallmark nutritional syndrome of cancer is cachexia, a wasting condition marked by weight loss, muscle breakdown, and a profound disinterest in food. Yet certain cancers, and especially certain cancer treatments, can push hunger in the opposite direction. The relationship between cancer and appetite is not one-size-fits-all, and understanding when and why hunger spikes or crashes matters for anyone navigating a diagnosis.
Why Cancer Usually Suppresses Appetite
The brain regulates hunger through a network of hormones and signaling molecules that communicate between the gut, fat tissue, and the hypothalamus. In many cancer patients, this signaling becomes badly distorted. A review in the Journal of Clinical Oncology described cancer-related anorexia as the result of an imbalance between appetite-stimulating and appetite-suppressing signals in the brain, with the suppressive side winning out.1Journal of Clinical Oncology. Appetite and cancer-associated anorexia: a review The tumor itself, and the immune system’s response to it, flood the body with inflammatory molecules like TNF-alpha and interleukin-1. These cytokines interfere with normal hunger cues and ramp up the production of leptin, a hormone that normally tells the brain you have eaten enough. Even as the body wastes away, leptin levels can stay elevated, preventing the compensatory hunger that would normally kick in when someone is losing weight.2Cancer Research. Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key?
At the same time, many cancer patients are burning through calories faster than expected. A prospective study of 390 cancer patients found that roughly half were hypermetabolic before treatment even began, meaning their bodies consumed more energy at rest than normal. Despite this increased demand, their food intake was no higher than that of patients with normal metabolic rates. The result was a negative energy balance in nearly half of the hypermetabolic group, and significant weight loss was almost twice as likely in those patients compared to those with normal resting metabolism.3The American Journal of Clinical Nutrition. Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy So the typical picture in cancer is not hunger but the opposite: the body needs more fuel and simultaneously refuses to ask for it.
When Cancer Treatments Drive Hunger Up
If you or someone you know has experienced ravenous hunger during cancer treatment, the culprit is often not the cancer itself but the medications used to manage it. Corticosteroids, particularly dexamethasone, are among the most commonly prescribed supportive drugs in oncology. They control nausea, reduce swelling around tumors, and tamp down inflammation. They also reliably crank up appetite.
A study tracking side effects in chemotherapy patients receiving dexamethasone for nausea prevention found that about one in five reported a noticeable increase in appetite in the week following treatment, with 16% also reporting weight gain.4PubMed Central. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy The effect is even more dramatic in children. In a study of kids with acute lymphoblastic leukemia, daily caloric intake jumped significantly during dexamethasone pulses, with the children eating more protein, fat, carbohydrates, and sodium than before the steroid course started. Their intake of saturated fat and salt exceeded healthy ranges for their age.5Pediatric Blood & Cancer. Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia Parents often describe their child eating nonstop during steroid weeks and then barely touching food when the steroids stop.
The mechanism is straightforward: corticosteroids lower the brain’s sensitivity to satiety signals while simultaneously raising blood sugar. The body responds by demanding more food. This is not a sign that the cancer is growing or changing; it is a pharmacological side effect that typically eases once the steroid dose is reduced or stopped.
Appetite Stimulants Used Deliberately
For patients suffering from cancer-related wasting, oncologists sometimes prescribe drugs specifically to boost appetite. Megestrol acetate, a synthetic hormone, is the most widely studied of these. A Cochrane review confirmed its use for anorexia-cachexia syndrome in cancer patients.6PubMed Central. Megestrol acetate for treatment of anorexia-cachexia syndrome Early clinical data showed that weight gain occurred in roughly a quarter of patients taking conventional doses, and at higher doses nearly all patients in one trial gained weight, with a median gain of about five kilograms. Most patients reported feeling subjectively hungrier.7PubMed. Appetite stimulation with megestrol acetate in cachectic cancer patients
THC-based medications have also been tested. In a phase II study, thirteen out of nineteen cancer patients with anorexia reported improved appetite after taking oral THC three times daily for four weeks.8Journal of Palliative Care. A Phase II Study of Delta-9-Tetrahydrocannabinol for Appetite Stimulation in Cancer-Associated Anorexia So yes, some cancer patients do experience increased hunger, but it is often deliberately induced by their medical team to combat dangerous weight loss, not caused by the disease running wild.
Rare Tumors That Actually Make You Hungry
There are a handful of uncommon cancers that can genuinely trigger persistent hunger as a direct symptom. These are the exceptions that prove the rule, and they work through very specific biological mechanisms.
Insulinomas are tumors of the insulin-producing cells in the pancreas. They secrete excess insulin, which drives blood sugar dangerously low. Your body reads low blood sugar as starvation, and the result is intense hunger alongside sweating, shakiness, and confusion.9The Journal of Clinical Endocrinology & Metabolism. Approach to the Patient: Insulinoma – Section: Diagnosis and Presentation People with undiagnosed insulinomas often find themselves eating constantly to keep symptoms at bay, and they may gain significant weight before anyone suspects a tumor. A related phenomenon, non-islet cell tumor hypoglycemia, occurs when other types of tumors produce a molecule that mimics insulin’s effects, activating insulin receptors and causing the same blood-sugar crashes and hunger.10PubMed Central. Non-islet cell tumor hypoglycemia concurrent with acromegalic features: A case report and literature review
Craniopharyngiomas are brain tumors that grow near the hypothalamus, the region that acts as the body’s appetite thermostat. When these tumors or the surgery to remove them damage the posterior hypothalamus, patients can develop severe, unrelenting hunger and obesity that resists typical weight-management strategies. Research has confirmed that injuries to specific hypothalamic areas from these tumors are linked to eating disorders and dramatic weight gain in long-term survivors, particularly children.11PubMed Central. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity The hunger these patients feel is not psychological; it is the result of physical damage to the brain’s satiety circuitry.
A third category involves neuroendocrine tumors that secrete ghrelin, sometimes called the “hunger hormone.” Ghrelin normally rises before meals and drops after eating, telling your brain it is time to eat. Some gastrointestinal neuroendocrine tumors release ghrelin continuously, which could theoretically keep the hunger signal locked in the “on” position.12PubMed Central. Ghrelin in neuroendocrine tumors These tumors are rare, and the clinical significance of their ghrelin secretion is still being studied, but they represent a real if uncommon pathway from cancer to increased appetite.
How Cancer Scrambles Blood Sugar
Even in cancers that do not directly produce insulin or insulin-like molecules, glucose metabolism often goes haywire. Research examining over 600 cancer patients found that more than a third showed a diabetic pattern on glucose tolerance testing, with abnormally high rates of glucose production by the liver. Tumor tissue itself is an outsized consumer of glucose, using anaerobic pathways that generate lactate as a byproduct. That lactate cycles back to the liver, where it gets converted into more glucose, creating a metabolic loop that keeps glucose production elevated.13Journal of the American College of Nutrition. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer
What does this mean for hunger? For most patients, the metabolic chaos contributes to fatigue and wasting rather than appetite. But the swings in blood sugar can create brief episodes of hypoglycemia-driven hunger, particularly in patients with liver involvement or those who are not eating regularly. If you have cancer and find yourself with sudden, urgent cravings or lightheadedness between meals, unstable blood sugar is a plausible explanation worth mentioning to your medical team.
Weight Gain in Childhood Cancer Survivors
One population where cancer-related weight gain is not rare at all is childhood leukemia survivors. Children treated for acute lymphoblastic leukemia frequently gain excessive weight during treatment and maintain that higher weight long after therapy ends.14PubMed Central. Obesity in Childhood Cancer Survivors: Call for Early Weight Management The reasons stack up: prolonged corticosteroid courses suppress the child’s ability to feel full, reduced physical activity during treatment lowers calorie needs, and in some cases cranial radiation damages the hypothalamus in ways similar to what craniopharyngiomas do. The result is that these children can emerge from successful cancer treatment facing a lifelong struggle with appetite regulation and obesity. The hunger they experience during treatment is real and intense, and for some it persists because the treatments that saved their lives also altered how their brain manages satiety.
This is a genuinely different trajectory from adult cancer cachexia. An adult with advanced lung cancer and an eight-year-old midway through leukemia treatment can have opposite relationships with food, even though both have cancer. The disease, the tumor type, the treatment protocol, and the patient’s age all matter enormously.
The Gut Microbiome Connection
An emerging area of research concerns the role of the gut microbiome in cancer-related appetite changes. The trillions of bacteria in your digestive tract produce metabolites that influence hunger signaling, immune function, and how the gut barrier holds up under stress. In cancer patients, the microbiome often shifts dramatically, both because of the disease itself and because of treatments like chemotherapy and antibiotics. Recent work has highlighted how these microbial changes may contribute to cachexia through immune activation, weakened gut barriers, and disrupted metabolic signaling.15Genes & Nutrition. Gut microbiota in cancer cachexia: a new frontier for research and therapy
The practical takeaway here is still developing. Researchers are exploring whether restoring healthier microbial communities through probiotics, diet, or other interventions could help stabilize appetite in cancer patients. No standard-of-care treatment has emerged yet, but the idea that your gut bacteria might be part of why food seems unappealing during cancer, or why your appetite is hard to predict, is gaining scientific traction.
Sorting Out What Is Causing Your Hunger Changes
If you have cancer and feel hungry all the time, a few practical questions can help narrow down what is going on:
- Check your medications: Corticosteroids like dexamethasone and prednisone are the most common treatment-related cause of increased appetite. If your hunger tracks with your steroid schedule, that is almost certainly the driver.
- Note the timing: Hunger that comes in sudden, urgent waves with shakiness or sweating may point to blood sugar instability rather than true increased appetite. This is worth flagging to your oncologist.
- Consider emotional eating: Anxiety, boredom during treatment, and the psychological weight of a cancer diagnosis can all shift eating patterns in ways that feel like increased hunger but are driven by emotional needs.
- Watch for patterns across treatment cycles: Many patients experience appetite swings that mirror their chemotherapy cycles, with some days of increased hunger (often steroid days) followed by days of nausea and food aversion.
None of these scenarios mean your cancer is getting worse because you feel hungry. The reflexive worry that increased appetite signals tumor growth is understandable but, for the vast majority of common cancers, unfounded. The tumors most likely to directly cause hunger, like insulinomas and hypothalamic tumors, produce very distinctive symptoms that your medical team would typically investigate early.
Why the “Cancer Equals Wasting” Stereotype Misleads
Popular culture has deeply embedded the image of cancer as a wasting disease, and for many patients that image is accurate. But it creates a problem: patients who gain weight during treatment, or who feel hungrier than expected, sometimes worry that something unusual or wrong is happening. Parents of children on steroid-heavy leukemia protocols can feel alarmed when their child eats voraciously and puts on weight rapidly. Adults on dexamethasone for brain metastases may feel confused when their appetite surges even as they are told their prognosis is serious.
The reality is that cancer’s relationship with appetite is bidirectional and context-dependent. The same disease category that causes devastating weight loss in one patient can trigger weight gain in another, depending on tumor location, treatment regimen, hormonal effects, and individual metabolism. Roughly half of all cancer patients are hypermetabolic before treatment starts, burning more energy at rest, but that does not always translate into feeling hungrier.3The American Journal of Clinical Nutrition. Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy Meanwhile, some patients on specific drug regimens gain weight they did not expect and struggle to lose it after treatment ends.
If you are dealing with unexpected hunger or weight changes during cancer treatment, bringing it up with your care team is always reasonable. Appetite changes are clinical data, and your oncologist and dietitian can help determine whether a medication adjustment, nutritional strategy, or further workup is warranted. The answer to whether cancer makes you hungry all the time is “usually no, but sometimes yes, and the reasons matter.”